These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16435446)

  • 1. New tuberculosis therapy offers potential shorter treatment.
    Indian J Med Sci; 2005 Dec; 59(12):556-7. PubMed ID: 16435446
    [No Abstract]   [Full Text] [Related]  

  • 2. Gatifloxacin in combination with rifampicin in a murine tuberculosis model.
    Cynamon M; Sklaney MR; Shoen C
    J Antimicrob Chemother; 2007 Aug; 60(2):429-32. PubMed ID: 17561504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gatifloxacin.
    Tuberculosis (Edinb); 2008 Mar; 88(2):109-11. PubMed ID: 18486044
    [No Abstract]   [Full Text] [Related]  

  • 4. A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project.
    Merle CS; Sismanidis C; Sow OB; Gninafon M; Horton J; Lapujade O; Lo MB; Mitchinson DA; Perronne C; Portaels F; Odhiambo J; Olliaro P; Rustomjee R; Lienhardt C; Fielding K
    Trials; 2012 May; 13():61. PubMed ID: 22607233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shortening treatment of tuberculosis: lessons from fluoroquinolone trials.
    Nimmo C; Lipman M; Phillips PP; McHugh T; Nunn A; Abubakar I
    Lancet Infect Dis; 2015 Feb; 15(2):141-3. PubMed ID: 25749057
    [No Abstract]   [Full Text] [Related]  

  • 6. Moxifloxacin and gatifloxacin for initial therapy of tuberculosis: a meta-analysis of randomized clinical trials.
    Ruan Q; Liu Q; Sun F; Shao L; Jin J; Yu S; Ai J; Zhang B; Zhang W
    Emerg Microbes Infect; 2016 Feb; 5(2):e12. PubMed ID: 26905025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolones: an important class of antibiotics against tuberculosis.
    De Souza MV; Vasconcelos TR; de Almeida MV; Cardoso SH
    Curr Med Chem; 2006; 13(4):455-63. PubMed ID: 16475933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones for the treatment of pulmonary tuberculosis.
    Moadebi S; Harder CK; Fitzgerald MJ; Elwood KR; Marra F
    Drugs; 2007; 67(14):2077-99. PubMed ID: 17883288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Tuberculosis. III. Current and Prospective Approaches in Anti-Tubercular Therapy.
    Sgaragli G; Frosini M; Saponara S; Corelli F
    Curr Med Chem; 2016; 23(21):2245-74. PubMed ID: 27142291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortening Tuberculosis Treatment With Fluoroquinolones: Lost in Translation?
    Lanoix JP; Chaisson RE; Nuermberger EL
    Clin Infect Dis; 2016 Feb; 62(4):484-90. PubMed ID: 26527614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New tuberculosis therapy offers potential shorter treatment.
    Wkly Epidemiol Rec; 2006 Jan; 81(2):19-20. PubMed ID: 16671244
    [No Abstract]   [Full Text] [Related]  

  • 12. Accelerating the transition of new tuberculosis drug combinations from Phase II to Phase III trials: New technologies and innovative designs.
    Davies G; Boeree M; Hermann D; Hoelscher M
    PLoS Med; 2019 Jul; 16(7):e1002851. PubMed ID: 31287813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Fluoroquinolones in the Treatment of Tuberculosis in 2019.
    Pranger AD; van der Werf TS; Kosterink JGW; Alffenaar JWC
    Drugs; 2019 Feb; 79(2):161-171. PubMed ID: 30617959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial tests new combination of drugs to treat tuberculosis.
    Roehr B
    BMJ; 2012 Mar; 344():e2216. PubMed ID: 22434129
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel drug combination for tuberculosis to be tested across 50 sites.
    Bagcchi S
    BMJ; 2014 May; 348():g3535. PubMed ID: 24868091
    [No Abstract]   [Full Text] [Related]  

  • 16. [Respiratory fluoroquinolones and pulmonary tuberculosis treatment when the main drugs are ineffective].
    Lazareva NB; Khaĭmenova TIu; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):14-20. PubMed ID: 19069177
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of fluoroquinolones for the treatment of TB: 8 years of experience.
    Ferrand H; Blanc-Gruyelle AL; Amsilli M; Lemaire X; Papot E; Papy E; Bervar J; Senneville E; Bouvet E; Yazdanpanah Y
    J Antimicrob Chemother; 2015 Nov; 70(11):3166-7. PubMed ID: 26260132
    [No Abstract]   [Full Text] [Related]  

  • 18. A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
    Rustomjee R; Lienhardt C; Kanyok T; Davies GR; Levin J; Mthiyane T; Reddy C; Sturm AW; Sirgel FA; Allen J; Coleman DJ; Fourie B; Mitchison DA;
    Int J Tuberc Lung Dis; 2008 Feb; 12(2):128-38. PubMed ID: 18230244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Present and future in the use of anti-tubercular drugs].
    Didilescu C; Craiova UM
    Pneumologia; 2011; 60(4):198-201. PubMed ID: 22420168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of drug resistant destructive pulmonary tuberculosis: gemifloxacin and other fluoroquinolones clinical efficiency and tolerance at the end of initial phase of treatment].
    Petrenko VI; Radysh HV
    Lik Sprava; 2013 Dec; (8):55-63. PubMed ID: 25726677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.